Ergolin 0.125mg Tablet 10’S
Original price was: ₹100.20.₹95.00Current price is: ₹95.00.
INTRODUCTION ABOUT ERGOLIN 0.125MG TABLET
ERGOLIN 0.125MG TABLET contains Methylergometrine which belongs to a group of medicines called Ergot alkaloids. ERGOLIN 0.125MG TABLET is used in the routine management of uterine atony (inability of the uterus to contract sufficiently during and after childbirth), haemorrhage and subinvolution of the uterus (delayed return of enlarged uterus to normal size) following delivery of placenta.
ERGOLIN 0.125MG TABLET is also used to control uterine haemorrhage (heavy/unusual bleeding from uterus) following delivery of anterior shoulder of the foetus (childbirth).
HOW ERGOLIN 0.125MG TABLET WORKS
ERGOLIN 0.125MG TABLET works by causing sustained contractions of uterine smooth muscles by acting directly on the uterine smooth muscle which leads to compression of blood vessels resulting in controlled/reduced blood loss following childbirth.
DIRECTIONS FOR USE
Take ERGOLIN 0.125MG TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
SIDE EFFECTS OF ERGOLIN 0.125MG TABLET
COMMON
- hypertension associated with seizure, and/or headache
RARE
- chest pain, fast/rapid/slow heart rate, coronary arterial spasm (sudden tightening of arteries of heart), heart attack
- vasoconstriction, vasospasm (narrowing of brain blood vessel)
- shortness of breath
- hematuria (blood in urine)
- thrombophlebitis (inflammation of a vein)
- hallucinations, dizziness
- leg cramps, ringing in ears, nasal congestion
- diarrhoea
- diaphoresis (sweating at a usual degree)
- rash
- foul taste
- signs of anaphylaxis reaction (life threatening allergic reaction) such as red itchy welts, low blood pressure, wheezing, and/or trouble in breathing
HOW TO MANAGE SIDE EFFECTS
Diarrhoea:
Drink plenty of water and stay hydrated. Try to avoid taking any medicine on your own to manage diarrhea. Consult and inform your doctor if the symptom worsens.
Rash:
Do not scratch the affected area. Wear protective clothing while going outdoors. Regularly moisturize your skin. Consult and inform your doctor if the symptom gets worse.
Dizziness:
Try to rest and get enough sleep. Try to avoid driving or operating any tools or machines while you feel dizzy. Limit consumption of alcohol, as it can aggravate dizziness. Consult and inform your doctor if the symptom worsens.
WARNING & PRECAUTIONS
PREGNANCY
ERGOLIN 0.125MG TABLET is generally not recommended for use during pregnancy. Consult your doctor before taking ERGOLIN 0.125MG TABLET.
BREASTFEEDING
ERGOLIN 0.125MG TABLET is generally not recommended for use in breast feeding women since the medicine may pass through breast milk. Consult your doctor before taking ERGOLIN 0.125MG TABLET.
KIDNEY
ERGOLIN 0.125MG TABLET should be used with caution in patients with kidney problems such as impaired renal function. Consult your doctor before taking the medicine.
LIVER
ERGOLIN 0.125MG TABLET should be used with caution in patients with liver problems such as impaired hepatic function. Consult your doctor before taking the medicine.
ALLERGY
Do not take ERGOLIN 0.125MG TABLET if you are allergic to Methylergometrine, and/or any other ingredients of this medicine.
HEART DISEASE
ERGOLIN 0.125MG TABLET should be used with caution in patients with heart problems such as coronary artery disease. Consult your doctor before taking the medicine.
OTHERS
ERGOLIN 0.125MG TABLET is not recommended for use if you:
- have high blood pressure
- suffer from toxemia (blood poisoning due to local bacterial infection)
Before taking ERGOLIN 0.125MG TABLET, inform your doctor if you:
- are a smoker
- suffer from high cholesterol, obesity, diabetes
- have obliterative vascular disease (gradual narrowing of arterial blood vessel), and/or suffer from sepsis (life threatening complication of an infection)
- are in second stage of labor
Use in Geriatrics:
ERGOLIN 0.125MG TABLET should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before taking the medicine.
INTERACTIONS
A. Drug-Drug interactions:
Before taking ERGOLIN 0.125MG TABLET, inform your doctor if you are taking any of the following medicine:
- macrolide antibiotics (medicines used to manage bacterial infections) such as erythromycin, troleandomycin, clarithromycin
- HIV protease/reverse transcriptase inhibitors (medicines used to manage HIV) Ex. atazanavir, cobicistat, darunavir, delavirdine, fosamprenavir, indinavir, nelfinavir, ritonavir, saquinavir, nevirapine
- nefazodone, fluoxetine, fluvoxamine (medicines used to manage depression)
- fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, clotrimazole (medicines used to manage fungal disease)
- zileuton (used to manage asthma)
- rifampicin (used to manage infections)
- beta-blockers (used to manage high blood pressure) Ex. acebutolol, atenolol
- aesthetics (medicines used for the induction and maintenance of general anaesthesia) Ex. halothan, methoxyfluran
- glyceryl trinitrate (used to manage angina)
- prostaglandins (used to induce labor/abortion and manage postpartum haemorrhage)
B. Drug-Food interaction:
Grapefruit/or its juice may interact with this medicine and lead to unwanted side effects. Consult your doctor before taking any grapefruit products.
Overdosage:
If you or anyone else accidentally take too much of ERGOLIN 0.125MG TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are nausea, vomiting, oliguria (low urine output), abdominal pain, numbness, tingling of the extremities, rise in blood pressure, low blood pressure, respiratory depression, hypothermia (dangerous drop in body temperature), convulsions, and/or coma.
SYNOPSIS
Drug | :Â Â | Methylergometrine |
Pharmacological Category | :Â Â | Ergot alkaloid |
Therapeutic Indication | :  | Routine management of uterine atony, haemorrhage and subinvolution of the uterus (following delivery of placenta), Control uterine haemorrhage following childbirth      |
Dosage Forms | :Â Â | Tablet, Injection |
MORE INFORMATION
- Keep ERGOLIN 0.125MG TABLET out of reach of children
- Do not store ERGOLIN 0.125MG TABLET above 30°C
FAQs ABOUT ERGOLIN 0.125MG TABLET
What is ERGOLIN 0.125MG TABLET used for?
ERGOLIN 0.125MG TABLET is used in the routine management of uterine atony (inability of the uterus to contract sufficiently during and after childbirth), haemorrhage and subinvolution of the uterus (delayed return of enlarged uterus to normal size) following delivery of placenta. It is also used to control uterine haemorrhage (heavy/unusual bleeding from uterus) following delivery of anterior shoulder of the foetus (childbirth).
How ERGOLIN 0.125MG TABLET works?
ERGOLIN 0.125MG TABLET works by causing sustained contractions of uterine smooth muscles by acting directly on the uterine smooth muscle which leads to compression of blood vessels resulting in controlled/reduced blood loss following childbirth.
How to take ERGOLIN 0.125MG TABLET? Â
Take ERGOLIN 0.125MG TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
What are the most common side effects of taking ERGOLIN 0.125MG TABLET?
The most common side effect of taking ERGOLIN 0.125MG TABLET is hypertension associated with seizure, and/or headache. Consult your doctor if the side effect worsens.
Can ERGOLIN 0.125MG TABLET be used in pregnant and breastfeeding women?
No, ERGOLIN 0.125MG TABLET is not recommended for use in pregnant and breastfeeding women. Consult your doctor before taking the medicine.
REFERENCES
1. KD. Tripathi. Oxytocin and Other Drugs Acting on Uterus. Essentials of medical pharmacology. Seventh edition. 2013. Page – 331.
2. Bethesda. Methylergonovine. NIH National Library of Medicine. National center of biotechnology Information. Drugs and Lactation database [Internet]. October 2018. [Accessed on 29th Nov 2022]Â https://www.ncbi.nlm.nih.gov/books/NBK501342/
3. Novartis Pharmaceuticals Corporation. U.S. Food & Drug Administration (USFDA). [Revised in June 2012] [Accessed on 29th Nov 2022]Â https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/006035s078lbl.pdf
4. Green Cross Remedies. MORMET Tablet. [Accessed on 29th Nov 2022]Â https://greencrossindia.com/p/mormet-tablet.html
USEFUL DIAGNOSTIC TESTS
- Activated Partial Thromboplastin Time
- Complete Blood Count
- Prothrombin Time
- Thrombin Time
AUTHOR DETAILS
Weight | 17.5 g |
---|
General Inquiries
There are no inquiries yet.
Customer reviews
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.